COVID-19 Vaccine Uptake Moderately High for Residents at SNFs
Median of 77.8 percent of residents and 37.5 percent of staff members per facility received one or more doses of COVID-19 vaccine
Oncology Clinical Trials Decline During Pandemic
Decline in trial launches could have long-term negative impact, authors say
AstraZeneca Vaccine Guards Against Severe COVID-19 Illness
Researchers also found that a single dose of the vaccine was 76 percent effective at preventing COVID-19
Mutation That Helps Coronavirus Evade Vaccines Showing Up in British Variant
Worrisome mutation known as E484K appears to have arisen in 11 of more than 200,000 B.1.1.7 coronavirus variant samples in the United Kingdom
Perioperative Chemo Feasible for Resectable Pancreatic Cancer
Phase 2 randomized trial revealed similar overall survival for two active regimens compared with adjuvant therapy
>60 Percent Receiving COVID-19 Vaccine in U.S. Are Non-Hispanic Whites
Of those having received their first dose by Jan. 14, 2021, 63.0 percent were women, 55.0 percent were aged 50 years and older
Moderna Wants to Increase Number of Doses in COVID-19 Vaccine Vials
However, there are potential downsides to putting more vaccine in each vial
Dexmedetomidine No Better Than Propofol for Adults With Sepsis
For light sedation of mechanically ventilated patients with sepsis, number of days alive without delirium or coma similar between groups
Regular Aspirin Use Before Diagnosis May Cut CRC Mortality
Long-term aspirin use before diagnosis also linked to lower odds of diagnosis with distant metastases
Rifaximin Prevents Overt Hepatic Encephalopathy After TIPS
For patients with cirrhosis, rifaximin reduces odds of overt HE after transjugular intrahepatic portosystemic shunt